Lord, Abbett & Co
RMD icon

Lord, Abbett & Co’s ResMed RMD Stock Holding History

Lord, Abbett & Co’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,243
Closed -$5.86M – 673
2021
Q3 		$5.86M Buy
+22,243
New +$6.08M 0.01% 579
2017
Q2 		– Sell
-141,100
Closed -$10.2M – 920
2017
Q1 		$10.2M Buy
+141,100
New +$9.75M 0.03% 599
2016
Q1 		– Sell
-55,967
Closed -$3M – 932
2015
Q4 		$3M Sell
55,967
-61,520
-52% -$3.47M 0.01% 803
2015
Q3 		$5.99M Sell
117,487
-114,781
-49% -$6.18M 0.02% 695
2015
Q2 		$13.1M Sell
232,268
-61,907
-21% -$3.91M 0.03% 587
2015
Q1 		$21.1M Sell
294,175
-51,711
-15% -$3.36M 0.05% 474
2014
Q4 		$19.4M Sell
345,886
-53,441
-13% -$2.79M 0.05% 474
2014
Q3 		$19.7M Buy
399,327
+319,973
+403% +$16.3M 0.05% 498
2014
Q2 		$4.03M Sell
79,354
-412,855
-84% -$20.5M 0.01% 838
2014
Q1 		$22M Buy
492,209
+350,070
+246% +$15.7M 0.05% 482
2013
Q4 		$6.69M Buy
+142,139
New +$7.19M 0.01% 760

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Lord, Abbett & Co's RMD Position: Q4 2021 in Review

Lord, Abbett & Co sold out of ResMed (RMD) in Q4 2021, closing a stake of 22,243 shares — an estimated $5.86M sold.

Lord, Abbett & Co first reported a position in RMD in Q4 2013 and held it in 11 quarters. The position peaked at $22M in Q1 2014. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

  • Lord, Abbett & Co reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 22,243 ResMed shares in Q4 2021, an estimated $5.86M.
  • Lord, Abbett & Co first reported a position in ResMed in Q4 2013 and held it in 11 quarters.
  • Lord, Abbett & Co's ResMed position peaked at $22M in Q1 2014.
  • 723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.